Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Seok Jang

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
BMC Cancer|November 29, 2008
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysisByung Ock Choi, Ihl Bohng Choi, Hong Seok Jang, et al.
Medicine|August 8, 2015
KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative SurgeryJeong Won Lee, Jong Hoon Lee, Byoung Yong Shim, et al.
Annals of Surgical Treatment and Research|January 24, 2022
Short- and long-term outcomes of local excision with adjuvant radiotherapy in high-risk T1 rectal cancer patientsAbdullah Al-Sawat, Jung Hoon Bae, Hyun Ho Kim, et al.
BMC Cancer|September 4, 2010
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancerJung Hyun Kwon, Si Hyun Bae, Ji Yoon Kim, et al.
Prostate International|July 10, 2015
Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancerYong Hyun Park, In Young Choi, Sei Chul Yoon, et al.
Cancer Research and Treatment|February 13, 2014
High-dose-rate brachytherapy for the treatment of vaginal intraepithelial neoplasiaJin Ho Song, Joo Hwan Lee, Jong Hoon Lee, et al.
Radiation Oncology (London, England)|January 10, 2013
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinomaSeok Hyun Son, Chul Seung Kay, Jin Ho Song, et al.
Cancer Research and Treatment|March 14, 2023
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II TrialsSoo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2018
Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching StudyMi Joo Chung, Joo Hwan Lee, Jong Hoon Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective AnalysisSooYoon Sung, Sung Hwan Kim, Joo Hwan Lee, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
BMC Cancer|November 29, 2008
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysisByung Ock Choi, Ihl Bohng Choi, Hong Seok Jang, et al.
Medicine|August 8, 2015
KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative SurgeryJeong Won Lee, Jong Hoon Lee, Byoung Yong Shim, et al.
Annals of Surgical Treatment and Research|January 24, 2022
Short- and long-term outcomes of local excision with adjuvant radiotherapy in high-risk T1 rectal cancer patientsAbdullah Al-Sawat, Jung Hoon Bae, Hyun Ho Kim, et al.
BMC Cancer|September 4, 2010
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancerJung Hyun Kwon, Si Hyun Bae, Ji Yoon Kim, et al.
Prostate International|July 10, 2015
Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancerYong Hyun Park, In Young Choi, Sei Chul Yoon, et al.
Cancer Research and Treatment|February 13, 2014
High-dose-rate brachytherapy for the treatment of vaginal intraepithelial neoplasiaJin Ho Song, Joo Hwan Lee, Jong Hoon Lee, et al.
Radiation Oncology (London, England)|January 10, 2013
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinomaSeok Hyun Son, Chul Seung Kay, Jin Ho Song, et al.
Cancer Research and Treatment|March 14, 2023
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II TrialsSoo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2018
Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching StudyMi Joo Chung, Joo Hwan Lee, Jong Hoon Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective AnalysisSooYoon Sung, Sung Hwan Kim, Joo Hwan Lee, et al.
Pageof 11